Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 104

1.

CD200 is a useful diagnostic marker for identifying atypical chronic lymphocytic leukemia by flow cytometry.

Ting YS, Smith SABC, Brown DA, Dodds AJ, Fay KC, Ma DDF, Milliken S, Moore JJ, Sewell WA.

Int J Lab Hematol. 2018 May 27. doi: 10.1111/ijlh.12857. [Epub ahead of print]

PMID:
29806244
2.

Poor prognosis in patients with steroid refractory acute graft versus host disease treated with etanercept: a multi-centre analysis.

Ma CKK, García-Cadenas I, Fox ML, Ai S, Nivison-Smith I, Milliken ST, Dodds A, Fay K, Ma DDF, Martino R, Sierra J, Moore J.

Bone Marrow Transplant. 2018 May 24. doi: 10.1038/s41409-018-0215-4. [Epub ahead of print] No abstract available.

PMID:
29795434
3.

Self-assembled vertically aligned Au nanorod arrays for surface-enhanced Raman scattering (SERS) detection of Cannabinol.

Milliken S, Fraser J, Poirier S, Hulse J, Tay LL.

Spectrochim Acta A Mol Biomol Spectrosc. 2018 May 5;196:222-228. doi: 10.1016/j.saa.2018.01.030. Epub 2018 Jan 12.

PMID:
29453097
4.

Activity and Capacity Profile of Transplant Physicians and Centers in Australia and New Zealand.

Nivison-Smith I, Milliken S, Dodds AJ, Gottlieb D, Kwan J, Ma DDF, Shaw PJ, Tran S, Wilcox L, Szer J.

Biol Blood Marrow Transplant. 2018 Jan;24(1):169-174. doi: 10.1016/j.bbmt.2017.09.011. Epub 2017 Sep 28.

PMID:
28963078
5.

Impact of Allogeneic Hematopoietic Stem Cell Transplantation on the HIV Reservoir and Immune Response in 3 HIV-Infected Individuals.

Koelsch KK, Rasmussen TA, Hey-Nguyen WJ, Pearson C, Xu Y, Bailey M, Marks KH, Sasson SC, Taylor MS, Tantau R, Obeid S, Milner B, Morrissey O, Pinto AN, Suzuki K, Busch MP, Keating SM, Kaiser P, Yukl S, Wong JK, Hiener BM, Palmer S, Zaunders J, Post JJ, Chan DJ, Avery S, Milliken ST, Kelleher AD, Lewin SR, Cooper DA.

J Acquir Immune Defic Syndr. 2017 Jul 1;75(3):328-337. doi: 10.1097/QAI.0000000000001381.

PMID:
28350553
6.

Early treatment intensification with R-ICE and 90Y-ibritumomab tiuxetan (Zevalin)-BEAM stem cell transplantation in patients with high-risk diffuse large B-cell lymphoma patients and positive interim PET after 4 cycles of R-CHOP-14.

Hertzberg M, Gandhi MK, Trotman J, Butcher B, Taper J, Johnston A, Gill D, Ho SJ, Cull G, Fay K, Chong G, Grigg A, Lewis ID, Milliken S, Renwick W, Hahn U, Filshie R, Kannourakis G, Watson AM, Warburton P, Wirth A, Seymour JF, Hofman MS, Hicks RJ; Australasian Leukaemia Lymphoma Group (ALLG).

Haematologica. 2017 Feb;102(2):356-363. doi: 10.3324/haematol.2016.154039. Epub 2016 Nov 10.

7.

Is a biomarker-based diagnostic strategy for invasive aspergillosis cost effective in high-risk haematology patients?

Macesic N, Morrissey CO, Liew D, Bohensky MA, Chen SC, Gilroy NM, Milliken ST, Szer J, Slavin MA.

Med Mycol. 2017 Oct 1;55(7):705-712. doi: 10.1093/mmy/myw141.

PMID:
28131991
8.

Ecological restoration across the Mediterranean Basin as viewed by practitioners.

Nunes A, Oliveira G, Mexia T, Valdecantos A, Zucca C, Costantini EAC, Abraham EM, Kyriazopoulos AP, Salah A, Prasse R, Correia O, Milliken S, Kotzen B, Branquinho C.

Sci Total Environ. 2016 Oct 1;566-567:722-732. doi: 10.1016/j.scitotenv.2016.05.136. Epub 2016 May 27.

9.

Post-transplant lymphoproliferative disease in heart and lung transplantation: Defining risk and prognostic factors.

Kumarasinghe G, Lavee O, Parker A, Nivison-Smith I, Milliken S, Dodds A, Joseph J, Fay K, Ma DD, Malouf M, Plit M, Havryk A, Keogh AM, Hayward CS, Kotlyar E, Jabbour A, Glanville AR, Macdonald PS, Moore JJ.

J Heart Lung Transplant. 2015 Nov;34(11):1406-14. doi: 10.1016/j.healun.2015.05.021. Epub 2015 Jun 11.

PMID:
26279197
10.

Autologous hematopoietic stem cell transplant for systemic sclerosis improves anemia from gastric antral vascular ectasia.

Bhattacharyya A, Sahhar J, Milliken S, Ma D, Englert H, Tymms K, Danta M, Moore J.

J Rheumatol. 2015 Mar;42(3):554-5. doi: 10.3899/jrheum.141234. No abstract available.

PMID:
25729047
11.

Adrenal tumours: how to establish malignancy.

Toogood V, Milliken S, Morey A, Samaras K.

BMJ Case Rep. 2014 Dec 23;2014. pii: bcr2014203736. doi: 10.1136/bcr-2014-203736.

12.

Consensus guidelines for antifungal prophylaxis in haematological malignancy and haemopoietic stem cell transplantation, 2014.

Fleming S, Yannakou CK, Haeusler GM, Clark J, Grigg A, Heath CH, Bajel A, van Hal SJ, Chen SC, Milliken ST, Morrissey CO, Tam CS, Szer J, Weinkove R, Slavin MA.

Intern Med J. 2014 Dec;44(12b):1283-97. doi: 10.1111/imj.12595. Review.

PMID:
25482741
13.

Diabetic ketoacidosis secondary to L-asparaginase in acute lymphoblastic leukaemia.

Gifford G, Milliken S, Greenfield J.

Intern Med J. 2013 Aug;43(8):946-8. doi: 10.1111/imj.12216.

PMID:
23919338
14.

Length of stay variations between rural and urban patients with acute myeloid leukemia: a case-matched study.

Heinz SJ, Milliken S.

Aust Health Rev. 2013 Jun;37(3):397-401. doi: 10.1071/AH13021.

PMID:
23680024
15.

Galactomannan and PCR versus culture and histology for directing use of antifungal treatment for invasive aspergillosis in high-risk haematology patients: a randomised controlled trial.

Morrissey CO, Chen SC, Sorrell TC, Milliken S, Bardy PG, Bradstock KF, Szer J, Halliday CL, Gilroy NM, Moore J, Schwarer AP, Guy S, Bajel A, Tramontana AR, Spelman T, Slavin MA; Australasian Leukaemia Lymphoma Group and the Australia and New Zealand Mycology Interest Group.

Lancet Infect Dis. 2013 Jun;13(6):519-28. doi: 10.1016/S1473-3099(13)70076-8. Epub 2013 Apr 30.

PMID:
23639612
16.

Auto-HSCT induces sustained responses in severe systemic sclerosis patients failing pulse cyclophosphamide.

Moore J, Englert H, Furlong T, Poon T, Milliken S, Ma D.

Bone Marrow Transplant. 2012 Nov;47(11):1486-7. doi: 10.1038/bmt.2012.67. Epub 2012 Apr 23. No abstract available.

PMID:
22522570
17.

Effects of ultraviolet light on human serum 25-hydroxyvitamin D and systemic immune function.

Milliken SV, Wassall H, Lewis BJ, Logie J, Barker RN, Macdonald H, Vickers MA, Ormerod AD.

J Allergy Clin Immunol. 2012 Jun;129(6):1554-61. doi: 10.1016/j.jaci.2012.03.001. Epub 2012 Apr 12.

PMID:
22502796
18.

Participants' perspectives of high resolution anoscopy.

Hillman RJ, Pett S, Marriott D, Carr A, Cooper DA, Matthews GV, Brew BJ, Milliken S, Botes LP.

Sex Health. 2011 Jun;8(2):255-6. doi: 10.1071/SH10116. No abstract available.

PMID:
21592443
19.

GWAS of follicular lymphoma reveals allelic heterogeneity at 6p21.32 and suggests shared genetic susceptibility with diffuse large B-cell lymphoma.

Smedby KE, Foo JN, Skibola CF, Darabi H, Conde L, Hjalgrim H, Kumar V, Chang ET, Rothman N, Cerhan JR, Brooks-Wilson AR, Rehnberg E, Irwan ID, Ryder LP, Brown PN, Bracci PM, Agana L, Riby J, Cozen W, Davis S, Hartge P, Morton LM, Severson RK, Wang SS, Slager SL, Fredericksen ZS, Novak AJ, Kay NE, Habermann TM, Armstrong B, Kricker A, Milliken S, Purdue MP, Vajdic CM, Boyle P, Lan Q, Zahm SH, Zhang Y, Zheng T, Leach S, Spinelli JJ, Smith MT, Chanock SJ, Padyukov L, Alfredsson L, Klareskog L, Glimelius B, Melbye M, Liu ET, Adami HO, Humphreys K, Liu J.

PLoS Genet. 2011 Apr;7(4):e1001378. doi: 10.1371/journal.pgen.1001378. Epub 2011 Apr 21.

20.

Genome-wide association study of follicular lymphoma identifies a risk locus at 6p21.32.

Conde L, Halperin E, Akers NK, Brown KM, Smedby KE, Rothman N, Nieters A, Slager SL, Brooks-Wilson A, Agana L, Riby J, Liu J, Adami HO, Darabi H, Hjalgrim H, Low HQ, Humphreys K, Melbye M, Chang ET, Glimelius B, Cozen W, Davis S, Hartge P, Morton LM, Schenk M, Wang SS, Armstrong B, Kricker A, Milliken S, Purdue MP, Vajdic CM, Boyle P, Lan Q, Zahm SH, Zhang Y, Zheng T, Becker N, Benavente Y, Boffetta P, Brennan P, Butterbach K, Cocco P, Foretova L, Maynadié M, de Sanjosé S, Staines A, Spinelli JJ, Achenbach SJ, Call TG, Camp NJ, Glenn M, Caporaso NE, Cerhan JR, Cunningham JM, Goldin LR, Hanson CA, Kay NE, Lanasa MC, Leis JF, Marti GE, Rabe KG, Rassenti LZ, Spector LG, Strom SS, Vachon CM, Weinberg JB, Holly EA, Chanock S, Smith MT, Bracci PM, Skibola CF.

Nat Genet. 2010 Aug;42(8):661-4. doi: 10.1038/ng.626. Epub 2010 Jul 18.

21.

IL-7 receptor is expressed on adult pre-B-cell acute lymphoblastic leukemia and other B-cell derived neoplasms and correlates with expression of proliferation and survival markers.

Sasson SC, Smith S, Seddiki N, Zaunders JJ, Bryant A, Koelsch KK, Weatherall C, Munier ML, McGinley C, Yeung J, Mulligan SP, Moore J, Cooper DA, Milliken S, Kelleher AD.

Cytokine. 2010 Apr;50(1):58-68. doi: 10.1016/j.cyto.2009.12.001. Epub 2010 Jan 8.

PMID:
20060740
22.

Safety and efficacy of consecutive cycles of granulocyte-colony stimulating factor, and an intracoronary CD133+ cell infusion in patients with chronic refractory ischemic heart disease: the G-CSF in angina patients with IHD to stimulate neovascularization (GAIN I) trial.

Kovacic JC, Macdonald P, Feneley MP, Muller DW, Freund J, Dodds A, Milliken S, Tao H, Itescu S, Moore J, Ma D, Graham RM.

Am Heart J. 2008 Nov;156(5):954-63. doi: 10.1016/j.ahj.2008.04.034.

PMID:
19061712
23.

Description of a novel mutation leading to MYH9-related disease.

Burt RA, Joseph JE, Milliken S, Collinge JE, Kile BT.

Thromb Res. 2008;122(6):861-3. doi: 10.1016/j.thromres.2008.06.011. Epub 2008 Aug 3. No abstract available.

PMID:
18676005
24.

Antifungal prophylaxis in adult stem cell transplantation and haematological malignancy.

Slavin MA, Heath CH, Thursky KA, Morrissey CO, Szer J, Ling LM, Milliken ST, Grigg AP.

Intern Med J. 2008 Jun;38(6b):468-76. doi: 10.1111/j.1445-5994.2008.01723.x.

PMID:
18588520
25.

Hypocalcaemic cardiac failure post BMT secondary to unrecognized vitamin D deficiency.

Lee P, Milliken S, Center JR.

Bone Marrow Transplant. 2008 Sep;42(5):363-4. doi: 10.1038/bmt.2008.178. Epub 2008 Jun 23. No abstract available.

PMID:
18574443
26.

Acute neutropenic diverticulitis: a case report.

Ismail AK, Milliken S, Buckland ME.

Pathology. 2008 Jun;40(4):423-5. doi: 10.1080/00313020802036814. No abstract available.

PMID:
18446640
27.

Successful reduced-intensity conditioning allogeneic HSCT for HIV-related primary effusion lymphoma.

Bryant A, Milliken S.

Biol Blood Marrow Transplant. 2008 May;14(5):601-2. doi: 10.1016/j.bbmt.2008.01.010. Epub 2008 Mar 14. No abstract available.

28.

Neurofibromatosis: a young woman's journey--case study.

Milliken S.

J Neurosci Nurs. 2007 Dec;39(6):332-5.

PMID:
18186417
30.

Serum macrophage inhibitory cytokine 1 in rheumatoid arthritis: a potential marker of erosive joint destruction.

Brown DA, Moore J, Johnen H, Smeets TJ, Bauskin AR, Kuffner T, Weedon H, Milliken ST, Tak PP, Smith MD, Breit SN.

Arthritis Rheum. 2007 Mar;56(3):753-64.

31.

Atopy, exposure to pesticides and risk of non-Hodgkin lymphoma.

Vajdic CM, Fritschi L, Grulich AE, Kaldor JM, Benke G, Kricker A, Hughes AM, Turner JJ, Milliken S, Goumas C, Armstrong BK.

Int J Cancer. 2007 May 15;120(10):2271-4.

32.

A SYBR green-based real-time PCR method for detection of haemopoietic chimerism in allogeneic haemopoietic stem cell transplant recipients.

Bai L, Deng YM, Dodds AJ, Milliken S, Moore J, Ma DD.

Eur J Haematol. 2006 Nov;77(5):425-31. Epub 2006 Aug 10.

PMID:
16899058
33.

Specific infections, infection-related behavior, and risk of non-Hodgkin lymphoma in adults.

Vajdic CM, Grulich AE, Kaldor JM, Fritschi L, Benke G, Hughes AM, Kricker A, Turner JJ, Milliken S, Armstrong BK.

Cancer Epidemiol Biomarkers Prev. 2006 Jun;15(6):1102-8.

34.

Occupational exposure to pesticides and risk of non-Hodgkin's lymphoma.

Fritschi L, Benke G, Hughes AM, Kricker A, Turner J, Vajdic CM, Grulich A, Milliken S, Kaldor J, Armstrong BK.

Am J Epidemiol. 2005 Nov 1;162(9):849-57. Epub 2005 Sep 21.

PMID:
16177143
35.

WHO non-Hodgkin's lymphoma classification by criterion-based report review followed by targeted pathology review: an effective strategy for epidemiology studies.

Turner JJ, Hughes AM, Kricker A, Milliken S, Grulich A, Kaldor J, Armstrong B.

Cancer Epidemiol Biomarkers Prev. 2005 Sep;14(9):2213-9.

36.

Risk of non-Hodgkin lymphoma associated with occupational exposure to solvents, metals, organic dusts and PCBs (Australia).

Fritschi L, Benke G, Hughes AM, Kricker A, Vajdic CM, Grulich A, Turner J, Milliken S, Kaldor J, Armstrong BK.

Cancer Causes Control. 2005 Jun;16(5):599-607.

PMID:
15986116
37.

Birth order, atopy, and risk of non-Hodgkin lymphoma.

Grulich AE, Vajdic CM, Kaldor JM, Hughes AM, Kricker A, Fritschi L, Turner JJ, Milliken S, Benke G, Armstrong BK.

J Natl Cancer Inst. 2005 Apr 20;97(8):587-94.

PMID:
15840881
38.

Sun exposure may protect against non-Hodgkin lymphoma: a case-control study.

Hughes AM, Armstrong BK, Vajdic CM, Turner J, Grulich AE, Fritschi L, Milliken S, Kaldor J, Benke G, Kricker A.

Int J Cancer. 2004 Dec 10;112(5):865-71.

39.

Clinical features and predictors of survival of AIDS-related non-Hodgkin's lymphoma in a population-based case series in Sydney, Australia.

Robotin MC, Law MG, Milliken S, Goldstein D, Garsia RJ, Dolan GM, Kaldor JM, Grulich AE.

HIV Med. 2004 Sep;5(5):377-84.

40.

A phase II study of Rituximab in rheumatoid arthritis patients with recurrent disease following haematopoietic stem cell transplantation.

Moore J, Ma D, Will R, Cannell P, Handel M, Milliken S.

Bone Marrow Transplant. 2004 Aug;34(3):241-7.

PMID:
15235579
41.

Castleman's disease and HIV infection in Australia.

Loi S, Goldstein D, Clezy K, Milliken ST, Hoy J, Chipman M.

HIV Med. 2004 May;5(3):157-62.

42.

Pigmentary characteristics, sun sensitivity and non-Hodgkin lymphoma.

Hughes AM, Armstrong BK, Vajdic CM, Turner J, Grulich A, Fritschi L, Milliken S, Kaldor J, Benke G, Kricker A.

Int J Cancer. 2004 Jun 20;110(3):429-34.

43.

Use of the WHO lymphoma classification in a population-based epidemiological study.

Turner JJ, Hughes AM, Kricker A, Milliken S, Grulich A, Kaldor J, Armstrong B.

Ann Oncol. 2004 Apr;15(4):631-7.

PMID:
15033672
44.

Autologous hemopoietic stem cell transplantation in severe rheumatoid arthritis: a report from the EBMT and ABMTR.

Snowden JA, Passweg J, Moore JJ, Milliken S, Cannell P, Van Laar J, Verburg R, Szer J, Taylor K, Joske D, Rule S, Bingham SJ, Emery P, Burt RK, Lowenthal RM, Durez P, McKendry RJ, Pavletic SZ, Espigado I, Jantunen E, Kashyap A, Rabusin M, Brooks P, Bredeson C, Tyndall A.

J Rheumatol. 2004 Mar;31(3):482-8.

PMID:
14994391
45.

A pilot randomized trial comparing CD34-selected versus unmanipulated hemopoietic stem cell transplantation for severe, refractory rheumatoid arthritis.

Moore J, Brooks P, Milliken S, Biggs J, Ma D, Handel M, Cannell P, Will R, Rule S, Joske D, Langlands B, Taylor K, O'Callaghan J, Szer J, Wicks I, McColl G, Passeullo F, Snowden J.

Arthritis Rheum. 2002 Sep;46(9):2301-9.

46.

Peripheral blood stem cell transplantation for rheumatoid arthritis--Australian experience.

Moore J, Milliken S, David, Biggs J, Brooks P.

J Rheumatol Suppl. 2001 Oct;64:8-12. Review.

PMID:
11642509
47.

Successful management of profound thrombocytopenia after lung and heart-lung transplantation.

Malouf MA, Milliken S, Glanville AR.

J Heart Lung Transplant. 2000 Jun;19(6):612-4. No abstract available.

PMID:
10867343
48.
49.

B-cell stimulation and prolonged immune deficiency are risk factors for non-Hodgkin's lymphoma in people with AIDS.

Grulich AE, Wan X, Law MG, Milliken ST, Lewis CR, Garsia RJ, Gold J, Finlayson RJ, Cooper DA, Kaldor JM.

AIDS. 2000 Jan 28;14(2):133-40.

PMID:
10708283
50.

Allogeneic PBPC transplantation: an effect on incidence and distribution of chronic graft-versus-host disease without long-term survival benefit?

Snowden JA, Nivison-Smith I, Atkinson K, Fay K, Concannon A, Dodds A, Milliken S, Biggs J.

Bone Marrow Transplant. 2000 Jan;25(1):119-20. No abstract available.

Supplemental Content

Loading ...
Support Center